These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21288988)

  • 1. HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.
    Disanto G; Magalhaes S; Handel AE; Morrison KM; Sadovnick AD; Ebers GC; Banwell B; Bar-Or A;
    Neurology; 2011 Mar; 76(9):781-6. PubMed ID: 21288988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
    van Pelt ED; Mescheriakova JY; Makhani N; Ketelslegers IA; Neuteboom RF; Kundu S; Broer L; Janssens C; Catsman-Berrevoets CE; van Duijn CM; Banwell B; Bar-Or A; Hintzen RQ
    Neurology; 2013 Dec; 81(23):1996-2001. PubMed ID: 24198294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk.
    Lavery AM; Collins BN; Waldman AT; Hart CN; Bar-Or A; Marrie RA; Arnold D; O'Mahony J; Banwell B
    Mult Scler; 2019 Apr; 25(4):515-522. PubMed ID: 29393768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of HLA-DRB1 alleles in a Hellenic, Pediatric-Onset Multiple Sclerosis cohort: Implications on clinical and neuroimaging profile.
    Skarlis C; Markoglou N; Gontika M; Artemiadis A; Pons MR; Stefanis L; Dalakas M; Chrousos G; Anagnostouli M
    Neurol Sci; 2024 Nov; 45(11):5405-5411. PubMed ID: 38819529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA.
    Cree BA; Reich DE; Khan O; De Jager PL; Nakashima I; Takahashi T; Bar-Or A; Tong C; Hauser SL; Oksenberg JR
    Arch Neurol; 2009 Feb; 66(2):226-33. PubMed ID: 19204159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common viruses associated with lower pediatric multiple sclerosis risk.
    Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Chabas D; Strober J; McDonald J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; Oksenberg JR; James JA;
    Neurology; 2011 Jun; 76(23):1989-95. PubMed ID: 21646624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.
    Tuwir I; Dunne C; Crowley J; Saddik T; Murphy R; Cassidy L
    Br J Ophthalmol; 2007 Oct; 91(10):1288-92. PubMed ID: 17895416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic risk variants in African Americans with multiple sclerosis.
    Isobe N; Gourraud PA; Harbo HF; Caillier SJ; Santaniello A; Khankhanian P; Maiers M; Spellman S; Cereb N; Yang S; Pando MJ; Piccio L; Cross AH; De Jager PL; Cree BA; Hauser SL; Oksenberg JR
    Neurology; 2013 Jul; 81(3):219-27. PubMed ID: 23771490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.
    Chao MJ; Barnardo MC; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Montpetit A; Sadovnick AD; Knight JC; Ebers GC
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13069-74. PubMed ID: 18765817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population.
    Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
    Eur J Neurol; 2011 Feb; 18(2):337-342. PubMed ID: 20629714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
    Cree BA; Rioux JD; McCauley JL; Gourraud PA; Goyette P; McElroy J; De Jager P; Santaniello A; Vyse TJ; Gregersen PK; Mirel D; Hafler DA; Haines JL; Pericak-Vance MA; Compston A; Sawcer SJ; Oksenberg JR; Hauser SL; ;
    PLoS One; 2010 Jun; 5(6):e11296. PubMed ID: 20593013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis.
    Ligers A; Dyment DA; Willer CJ; Sadovnick AD; Ebers G; Risch N; Hillert J;
    Am J Hum Genet; 2001 Oct; 69(4):900-3. PubMed ID: 11519010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
    Wu JS; Qiu W; Castley A; James I; Mastaglia FL; Christiansen FT; Carroll WM; Joseph J; Kermode AG
    Mult Scler; 2010 Jan; 16(1):15-20. PubMed ID: 19995849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies.
    Zhang Q; Lin CY; Dong Q; Wang J; Wang W
    Autoimmun Rev; 2011 Jun; 10(8):474-81. PubMed ID: 21440682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.